The U.S. Securities and Exchange Commission (SEC) has disclosed a new meeting with Injective Labs and the Blockchain Association concerning its recently introduced exemption for blockchain-based trading of tokenized U.S. stocks.
An October 14, 2026 memorandum from the SEC’s Crypto Task Force confirms that representatives of both organizations discussed, among other matters, the agency’s Innovation Exemption, which allows qualifying platforms to trade certain tokenized equities without registering as conventional securities exchanges.
The disclosure places Injective Labs directly in discussions surrounding one of the SEC’s most significant recent changes to securities-market regulation. However, the memorandum does not reveal whether Injective requested specific regulatory relief, intends to operate a qualifying trading venue or has submitted plans for a new U.S. securities product.
SEC Names Injective Representatives in October 14 Meeting
According to the SEC’s October 14 meeting memorandum, five Crypto Task Force staff members met with four representatives from Injective Labs and two from the Blockchain Association.
Injective’s participants were Noah Axler, Eric Chen, Brandon Goss and John Medel. The Blockchain Association was represented by Ashok Pinto and Jack Solowey.
The SEC staff participants were Taylor Lindman, Ileana Ciobanu, Rachel Li, Laura Powell and Phil Raimondi.
The one-page filing identifies Release No. 34-106402 and File No. 4-927, the regulatory proceeding covering the SEC’s exemption for certain distributed-ledger venues trading tokenized National Market System stocks.
No presentation materials, proposed business structure or specific requests from the participants are disclosed in the memorandum.
The meeting also builds on earlier contact between Injective and the regulator. A separate SEC record confirms that representatives of Injective Labs, Injective LLC and the Injective Foundation met with Crypto Task Force staff on January 13, 2026.
Materials associated with that earlier meeting show that Injective wanted to discuss potential U.S. compliance routes for tokenized real-world assets, including broker-dealer registration, transfer-agent requirements and alternative trading system licensing. Tokenized equities were explicitly included in its agenda.
The October meeting therefore represents a more specific, newly documented discussion of an exemption that has since entered into force, rather than Injective’s first expression of regulatory interest in tokenized stocks.
SEC’s Five-Year Exemption Creates a New Route for On-Chain Equities
The SEC introduced its Innovation Exemption on September 17, establishing temporary regulatory relief through September 17, 2031.
Under the framework, qualifying Tokenized Securities Venues (TSVs) can facilitate trading in eligible tokenized U.S. equities through permissioned automated market makers and liquidity pools without being classified as traditional exchanges under the relevant Exchange Act provision.
Certain liquidity providers may also qualify for exemptions from the definition of a securities dealer, subject to specified conditions.
The framework includes several restrictions. Tokenized shares must preserve the rights associated with the underlying securities, including dividends and voting privileges. Synthetic products offering price exposure without equivalent shareholder rights are excluded.
Trading activity is also capped. Tier 1 securities are limited to 75 symbols and 0.25% of the underlying stock’s average daily share volume in the preceding month. Tier 2 securities have limits of 250 symbols and 2.5%, respectively.
Qualifying operators must publish a detailed notice at least 30 calendar days before starting operations and inform the SEC of their intention to rely on the exemption. They must also provide transaction data, coordinate trading halts and satisfy operational safeguards.
The rules are explained further in Dave Finances’ earlier coverage of the SEC’s five-year tokenized stock trading framework.
The exemption does not amount to unrestricted permission for crypto companies to trade U.S. equities. Eligibility depends on the venue, securities structure and compliance with the SEC’s conditions.
Injective’s Financial Blockchain Strategy Provides the Context
Injective operates a layer-one blockchain designed around financial applications, including decentralized trading, derivatives and tokenized assets.
Its earlier SEC submissions described native financial infrastructure such as an on-chain order book, decentralized price oracles, smart-contract functionality and governance mechanisms.
The company’s regulatory engagement comes as traditional financial institutions and crypto-native firms increasingly pursue blockchain-based securities infrastructure.
On October 8, Securitize announced a tokenized-stock trading service offering blockchain-based representations of major U.S. equities, including Apple, Microsoft and Nvidia. Meanwhile, other companies are developing integrated platforms that combine conventional brokerage products with digital assets.
One example is ThinkEquity’s planned stocks-to-crypto trading platform, which illustrates how firms are developing financial infrastructure while navigating additional regulatory requirements.
Nothing in the October 14 memorandum establishes that Injective will launch a comparable service. The document confirms participation in regulatory discussions, not the approval or announcement of a commercial product.
Why Injective’s Direct Participation Matters
The interesting part of this disclosure is its timing.
Injective had already been talking to the SEC about decentralized finance and tokenization before the new exemption existed. Now its representatives have returned to discuss an actual framework that creates a route for certain on-chain stock trading.
That is a meaningful progression, even if the meeting reveals little about the company’s intentions.
For blockchain infrastructure developers, regulatory uncertainty has historically been one of the biggest obstacles to bringing traditional securities on-chain. Building an exchange, smart contract or settlement system is technically possible. Establishing who is legally allowed to operate it, who owns the underlying shares and which protections investors receive is considerably harder.
The exemption provides more clarity on those questions, but it does not eliminate them.
Injective could potentially benefit if developers choose its infrastructure for compliant financial applications. Yet there is a substantial difference between a blockchain being technically capable of supporting a securities marketplace and a regulated operator deciding to use that blockchain.
That distinction is particularly important for INJ investors. The native token’s market value does not automatically increase because Injective Labs participates in an SEC meeting.
Any sustained economic benefit would depend on actual adoption, network activity, transaction economics and whether new applications create meaningful demand for the token.
Tokenized Stocks Face a Tougher Test Than Crypto Derivatives
The SEC’s approach also creates an important distinction between putting stock prices on a blockchain and putting actual shareholder rights there.
Crypto markets already offer numerous instruments linked to equities. Traders can obtain exposure through perpetual contracts, certificates and other synthetic structures without owning the underlying shares.
Those products can attract trading volume, but they do not necessarily deliver the protections or rights associated with conventional securities.
That difference has become central to the debate over genuine versus synthetic tokenized stocks.
For a developer considering a compliant U.S. venue, satisfying the SEC’s rights requirements could involve custody arrangements, issuer communications, shareholder servicing and other obligations that cannot simply be handled by deploying a smart contract.
Liquidity is another concern. Automated market makers can provide continuous trading, but the SEC’s volume limits and requirements to coordinate stock-trading halts constrain how far these venues can operate independently of traditional exchanges.
Prices could also diverge when liquidity is thin or underlying markets are closed. Blockchain settlement alone does not guarantee efficient pricing.
What Investors Should Watch Next
The October disclosure is best understood as evidence of regulatory engagement, not evidence of an imminent Injective stock-trading launch.
The next important development would be a substantive filing or company statement explaining whether Injective intends to participate directly in the exemption, provide infrastructure to another operator or simply contribute policy recommendations.
Any public notice from a proposed Tokenized Securities Venue would be especially useful because the SEC’s framework requires operators to disclose their structure before commencing activity.
For investors, identifying the legal operator matters as much as identifying the blockchain. The differences between direct stock ownership and tokenized securities show why custody arrangements and shareholder protections cannot be inferred from a trading application’s branding.
Injective’s participation gives it a documented presence in discussions shaping the next generation of U.S. tokenized securities markets. Whether that presence eventually translates into a trading venue, infrastructure partnerships or measurable business activity remains an open question.
For now, the SEC filing is a regulatory development worth monitoring, not a product announcement or investment catalyst with a demonstrated financial impact.
Johan Shamshad is a financial markets writer at Dave Finances covering cryptocurrencies, trading platforms, brokers, fintech, financial regulation, and developments across global markets. He previously worked at Gulf News, adding newsroom experience to his coverage of fast-moving financial and digital-asset markets.
His work focuses on identifying market-moving events, company developments, regulatory changes, product launches, and shifts in trading and financial infrastructure.
Johan contributes news and analysis designed to help readers understand not only what happened, but why a development matters and how it may affect the wider financial landscape. You can reach out to him via his social media accounts:
Linkedin: https://www.linkedin.com/in/johan-shamshad-742851262/
X: https://x.com/Yasmine_FX
Investing: https://www.investing.com/members/contributors/279781574